No categories for this tab

About Us

About PharmaCountry
How It Works
Partnerships
Sustainability
Contact Us

For Buyers

Search Products
Search Services
Find Suppliers
Find Jobs
Find Seekers
Help Center
FAQ
Buyer Protection

For Sellers/Service Providers

Start Selling
Seller Guide
Pricing Plans
Advertising
Seller Support

Top Categories

Active Pharmaceutical Ingredients (APIs)
Finished Dosage Forms
Manufacturing Equipment & Utilities
Excipients & Additives
View All Categories

Stay Connected

[email protected]

24/7 Customer Support

Trusted B2B Platform

SSL Secure Transactions Verified Suppliers Quality Assured B2B Certified Global Network

© 2026 PharmaCountry. All rights reserved.

Privacy Policy Terms of Service Cookie Policy

VENLAPINE RETARD 75 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | Pharmacountry

Products
Finished Dosage Forms
Capsules
Extended-Release Capsules

VENLAPINE RETARD 75 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG

NS

Neuraxpharm Spain S.L.U.

Distributor · Finished Dosage FormsSpain

Ratings

(0)

(0)

(0)

(0)

(0)

Leave your rating & comment

Comments

Filters:

Sort by:

No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product

Basic Information

Category

Finished Dosage Forms

Subcategory & Sub-subcategory

Capsules / Extended-Release Capsules

Trade Type

Sell

Product Name

VENLAPINE RETARD 75 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG

Details

VENLAFAXINA HIDROCLORURO 84,86 mg

Substance

VENLAFAXINA HIDROCLORURO

Registered Market

Spain

Specifications

Dosage Form: Extended-release capsule
ATC Code: N06AX16
Packaging: VENLAPINE extended-release 75 mg hard capsules of prolonged release EFG, 28 capsules • VENLAPINE extended-release 75 mg hard capsules of prolonged release EFG, 30 capsules • VENLAPINE extended-release 75 mg hard capsules of prolonged release EFG, 98 capsules

Documents

Drug Marketing Authorization Number

Document No.: 69919

Issue Date: Jun 26, 2008